ACURA PHARMACEUTICALS, INCACUR
| Dec 31, 2011 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
---|
Cash | - | - | - | - | - | - | 0 | 1 | 0 | 0 |
---|
Royalty receivable | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Collaboration Revenue Receivable | - | - | - | - | 0 | - | - | 0 | 0 | 0 |
---|
License fees receivable from related party | - | - | - | - | - | - | - | - | 0 | 0 |
---|
Prepaid expenses and other current assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Total current assets | 36 | 27 | 13 | 14 | 6 | 3 | 0 | 1 | 1 | 0 |
---|
Finance lease right of use | - | - | - | - | - | - | - | - | - | 0 |
---|
Property, plant and equipment, net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
---|
Intangible asset, net | - | - | 2 | 2 | 1 | 1 | 1 | 1 | 0 | - |
---|
Total assets | 37 | 29 | 16 | 17 | 8 | 5 | 2 | 3 | 2 | 1 |
---|
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
---|
Accrued expenses | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
---|
Finance lease liability - current | - | - | - | - | - | - | - | - | - | 0 |
---|
Short-term Debt | - | - | - | - | - | - | - | - | 0 | - |
---|
Other current liabilities | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Accrued interest to related party | - | - | - | - | - | - | - | - | 1 | - |
---|
Long-term Debt, Current Maturities, Total | - | - | 2 | 2 | 2 | 3 | - | - | 6 | - |
---|
Total current liabilities | 1 | 1 | 3 | 3 | 3 | 5 | 1 | 1 | 8 | 1 |
---|
Finance lease liability - noncurrent | - | - | - | - | - | - | - | - | - | 0 |
---|
Loans under CARES Act - noncurrent | - | - | - | - | - | - | - | - | 0 | - |
---|
Promissory note to related party | - | - | - | - | - | - | - | - | - | 0 |
---|
Total liabilities | - | 11 | 11 | 9 | 7 | 5 | 6 | 7 | 8 | 1 |
---|
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
---|
Additional paid-in capital | 362 | 367 | 367 | 375 | 376 | 380 | 380 | 383 | 383 | 390 |
---|
Accumulated deficit | -326 | -349 | -362 | -367 | -375 | -380 | -384 | -388 | -389 | -390 |
---|
Total stockholders' equity (deficit) | 37 | 18 | 5 | 8 | 1 | -0 | -4 | -5 | -6 | 0 |
---|
Total liabilities and stockholders' equity (deficit) | 37 | 29 | 16 | 17 | 8 | 5 | 2 | 3 | 2 | 1 |
---|